River BioMedics

RyCarma

This biotechnology company develops small molecule therapeutics for patients with cardiovascular and skeletal muscle diseases, specifically heart failure and rare genetic myopathies.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.

Kadis Bio

This biotech developer produces induced pluripotent stem cell-derived therapies and cardiac organoids for patients with cardiovascular diseases and pharmaceutical companies conducting drug toxicity testing.

Cardior

This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.

AnaCardio

This biopharmaceutical company develops oral small-molecule drugs to improve cardiac contractility in patients with heart failure.

Braveheart Bio

This biopharmaceutical company develops small-molecule therapeutics to treat patients with hypertrophic cardiomyopathy and other serious cardiovascular conditions.

Acesion Pharma ApS

This biotech company develops small-molecule drugs to treat atrial fibrillation by inhibiting ion channels for patients with cardiac arrhythmia.

Secretome Therapeutics

This company develops regenerative cell therapies derived from neonatal cardiac progenitor cells for patients with heart failure and Duchenne muscular dystrophy associated cardiomyopathy.